CLOSTRIDIUM DIFFICILE TOXINS A AND/OR B ANTIGEN AND EPITOPE ANTIBODY, AND PHARMACEUTICAL USES THEREOF
It is described a Clostridium difficile (C-difficile) toxins A and/or B as a target for therapy, including passive immunotherapy, and particularly prevention of C-difficile intoxication in human or other animals. It is also described a polypeptide comprising a portion of C-difficile toxins A and/or...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | VERONNEAU, Steeve LEDUC, Frederic GBRIC, Djorjde GAUDREAU, Simon CLOUTIER, Martin TREMBLAY, Maxime FORTIER, Louis-charles LARRIVEE, Jean-François |
| description | It is described a Clostridium difficile (C-difficile) toxins A and/or B as a target for therapy, including passive immunotherapy, and particularly prevention of C-difficile intoxication in human or other animals. It is also described a polypeptide comprising a portion of C-difficile toxins A and/or B sequence being an epitope for anti-toxins A and/or B antibody. It is also disclosed a method for generating a neutralizing antibody directed against C-difficile toxins A and/or B. It is also provided a novel formulation that combines key toxins A and/or B epitope antibodies, located in three key domains of toxins A and/or B, for neutralisation of the toxins A and/or B, at any stage of toxins A and/or B intoxication related to C-difficile infection. The novel formulation of toxins A and/or B epitope antibodies are useful in immunotherapy, for therapeutic and/or prophylactic mediation of C-difficile intoxication. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3271375A4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3271375A4</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3271375A43</originalsourceid><addsrcrecordid>eNqNykEKwjAQheFsXIh6hzmAIlql6zSZmIE2CckUdFWKxJVood4ftXgAV-_n481FVrVPHElT24AmY0hRjcD-TC6BBOn01keoPsF0QvcFwEDsA05WeX1ZTxqsjI1U2DIpWUObMAFbjOjNUsxu_X3Mq98uBBhkZTd5eHZ5HPprfuRXh6HYl7uiPMpD8cflDeVbNAM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CLOSTRIDIUM DIFFICILE TOXINS A AND/OR B ANTIGEN AND EPITOPE ANTIBODY, AND PHARMACEUTICAL USES THEREOF</title><source>esp@cenet</source><creator>VERONNEAU, Steeve ; LEDUC, Frederic ; GBRIC, Djorjde ; GAUDREAU, Simon ; CLOUTIER, Martin ; TREMBLAY, Maxime ; FORTIER, Louis-charles ; LARRIVEE, Jean-François</creator><creatorcontrib>VERONNEAU, Steeve ; LEDUC, Frederic ; GBRIC, Djorjde ; GAUDREAU, Simon ; CLOUTIER, Martin ; TREMBLAY, Maxime ; FORTIER, Louis-charles ; LARRIVEE, Jean-François</creatorcontrib><description>It is described a Clostridium difficile (C-difficile) toxins A and/or B as a target for therapy, including passive immunotherapy, and particularly prevention of C-difficile intoxication in human or other animals. It is also described a polypeptide comprising a portion of C-difficile toxins A and/or B sequence being an epitope for anti-toxins A and/or B antibody. It is also disclosed a method for generating a neutralizing antibody directed against C-difficile toxins A and/or B. It is also provided a novel formulation that combines key toxins A and/or B epitope antibodies, located in three key domains of toxins A and/or B, for neutralisation of the toxins A and/or B, at any stage of toxins A and/or B intoxication related to C-difficile infection. The novel formulation of toxins A and/or B epitope antibodies are useful in immunotherapy, for therapeutic and/or prophylactic mediation of C-difficile intoxication.</description><language>eng ; fre ; ger</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180801&DB=EPODOC&CC=EP&NR=3271375A4$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180801&DB=EPODOC&CC=EP&NR=3271375A4$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VERONNEAU, Steeve</creatorcontrib><creatorcontrib>LEDUC, Frederic</creatorcontrib><creatorcontrib>GBRIC, Djorjde</creatorcontrib><creatorcontrib>GAUDREAU, Simon</creatorcontrib><creatorcontrib>CLOUTIER, Martin</creatorcontrib><creatorcontrib>TREMBLAY, Maxime</creatorcontrib><creatorcontrib>FORTIER, Louis-charles</creatorcontrib><creatorcontrib>LARRIVEE, Jean-François</creatorcontrib><title>CLOSTRIDIUM DIFFICILE TOXINS A AND/OR B ANTIGEN AND EPITOPE ANTIBODY, AND PHARMACEUTICAL USES THEREOF</title><description>It is described a Clostridium difficile (C-difficile) toxins A and/or B as a target for therapy, including passive immunotherapy, and particularly prevention of C-difficile intoxication in human or other animals. It is also described a polypeptide comprising a portion of C-difficile toxins A and/or B sequence being an epitope for anti-toxins A and/or B antibody. It is also disclosed a method for generating a neutralizing antibody directed against C-difficile toxins A and/or B. It is also provided a novel formulation that combines key toxins A and/or B epitope antibodies, located in three key domains of toxins A and/or B, for neutralisation of the toxins A and/or B, at any stage of toxins A and/or B intoxication related to C-difficile infection. The novel formulation of toxins A and/or B epitope antibodies are useful in immunotherapy, for therapeutic and/or prophylactic mediation of C-difficile intoxication.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNykEKwjAQheFsXIh6hzmAIlql6zSZmIE2CckUdFWKxJVood4ftXgAV-_n481FVrVPHElT24AmY0hRjcD-TC6BBOn01keoPsF0QvcFwEDsA05WeX1ZTxqsjI1U2DIpWUObMAFbjOjNUsxu_X3Mq98uBBhkZTd5eHZ5HPprfuRXh6HYl7uiPMpD8cflDeVbNAM</recordid><startdate>20180801</startdate><enddate>20180801</enddate><creator>VERONNEAU, Steeve</creator><creator>LEDUC, Frederic</creator><creator>GBRIC, Djorjde</creator><creator>GAUDREAU, Simon</creator><creator>CLOUTIER, Martin</creator><creator>TREMBLAY, Maxime</creator><creator>FORTIER, Louis-charles</creator><creator>LARRIVEE, Jean-François</creator><scope>EVB</scope></search><sort><creationdate>20180801</creationdate><title>CLOSTRIDIUM DIFFICILE TOXINS A AND/OR B ANTIGEN AND EPITOPE ANTIBODY, AND PHARMACEUTICAL USES THEREOF</title><author>VERONNEAU, Steeve ; LEDUC, Frederic ; GBRIC, Djorjde ; GAUDREAU, Simon ; CLOUTIER, Martin ; TREMBLAY, Maxime ; FORTIER, Louis-charles ; LARRIVEE, Jean-François</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3271375A43</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2018</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>VERONNEAU, Steeve</creatorcontrib><creatorcontrib>LEDUC, Frederic</creatorcontrib><creatorcontrib>GBRIC, Djorjde</creatorcontrib><creatorcontrib>GAUDREAU, Simon</creatorcontrib><creatorcontrib>CLOUTIER, Martin</creatorcontrib><creatorcontrib>TREMBLAY, Maxime</creatorcontrib><creatorcontrib>FORTIER, Louis-charles</creatorcontrib><creatorcontrib>LARRIVEE, Jean-François</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VERONNEAU, Steeve</au><au>LEDUC, Frederic</au><au>GBRIC, Djorjde</au><au>GAUDREAU, Simon</au><au>CLOUTIER, Martin</au><au>TREMBLAY, Maxime</au><au>FORTIER, Louis-charles</au><au>LARRIVEE, Jean-François</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CLOSTRIDIUM DIFFICILE TOXINS A AND/OR B ANTIGEN AND EPITOPE ANTIBODY, AND PHARMACEUTICAL USES THEREOF</title><date>2018-08-01</date><risdate>2018</risdate><abstract>It is described a Clostridium difficile (C-difficile) toxins A and/or B as a target for therapy, including passive immunotherapy, and particularly prevention of C-difficile intoxication in human or other animals. It is also described a polypeptide comprising a portion of C-difficile toxins A and/or B sequence being an epitope for anti-toxins A and/or B antibody. It is also disclosed a method for generating a neutralizing antibody directed against C-difficile toxins A and/or B. It is also provided a novel formulation that combines key toxins A and/or B epitope antibodies, located in three key domains of toxins A and/or B, for neutralisation of the toxins A and/or B, at any stage of toxins A and/or B intoxication related to C-difficile infection. The novel formulation of toxins A and/or B epitope antibodies are useful in immunotherapy, for therapeutic and/or prophylactic mediation of C-difficile intoxication.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3271375A4 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | CLOSTRIDIUM DIFFICILE TOXINS A AND/OR B ANTIGEN AND EPITOPE ANTIBODY, AND PHARMACEUTICAL USES THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T18%3A47%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VERONNEAU,%20Steeve&rft.date=2018-08-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3271375A4%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |